Dimethylamine

Dimethylamine

SCHEMBL4816626

CCOc1cccc2[nH]c(C(=O)O)cc12.CNC

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.66
POLB P06746 2/20 0.49
HDAC3 O15379 2/20 0.49
HDAC1 Q13547 2/20 0.49
DUSP3 P51452 1/20 0.49
PTPN5 P54829 1/20 0.49
PTPN11 Q06124 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
RCE1 Q9Y256 1/20 0.46
FLT3 P36888 2/20 0.46
IDO1 P14902 2/20 0.46
TDO2 P48775 1/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 3/20 0.46
CYP1A2 P05177 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144792 0.96 SRD5A2 (0.71) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL30310576 0.96 SRD5A2 (0.71) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL7044742 0.85 SRD5A2 (0.53) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL24020490 0.85 SRD5A2 (0.67) SRD5A2POLBNPC1RAB9AMEN1
SCHEMBL30310677 0.85 SRD5A2 (0.67) SRD5A2POLBNPC1RAB9AMEN1
SCHEMBL12596312 0.84 SRD5A2 (0.66) SRD5A2POLBDUSP3PTPN5PTPN11
SCHEMBL12084282 0.83 SRD5A2 (0.54) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL25852999 0.83 HDAC3 (0.58) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL24019971 0.82 KMT2A (0.59) SRD5A2POLBHDAC3HDAC1DUSP3
SCHEMBL914781 0.81 SRD5A2 (0.66) SRD5A2POLBNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2008-06-12 US disclosed
US-7368572-B2 Acetylene derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2008-05-06 US disclosed
EP-1656348-B1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARM INC (US) 2007-02-07 EP disclosed
EP-1656348-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS, INC. (US) 2006-05-17 EP disclosed
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2005-06-16 US disclosed
WO-2005019174-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS, INC. (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC10, HDAC2 SRD5A2 1090/4885POLB 433/4885HDAC3 6/4885
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase HDAC1, HDAC10, HDAC2 SRD5A2 1090/4885POLB 433/4885HDAC3 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.